Abaloparatide is a synthetic form of parathyroid hormone-related protein (PTHrP) used as a medication to treat postmenopausal osteoporosis. It is a subcutaneous injection used to reduce the risk of fractures in women at high risk of fractures due to osteoporosis. It is not recommended for use in people with low bone mass but no additional risk factors for fractures. Abaloparatide is also used off-label in some countries for the treatment of hypercalcemia.
Abaloparatide is a medication used to treat osteoporosis in postmenopausal women and men who are at high risk of fractures.expand_more It is sold under the brand name Tymlos.expand_more It works by increasing bone density and reducing the risk of fractures.
Abaloparatide is a synthetic form of a parathyroid hormone-related protein (PTHrP).expand_more PTHrP is a naturally occurring hormone that helps to regulate bone growth.expand_more Abaloparatide works by mimicking the effects of PTHrP on bone cells. This causes the body to produce new bone and increase bone density.expand_more
Abaloparatide is given as an injection under the skin (subcutaneously) once a day.expand_more The most common side effects of abaloparatide include back pain, leg pain, headache, nausea, and dizziness.
It is important to note that abaloparatide is not for everyone.expand_more It is not recommended for people with certain medical conditions, such as hypercalcemia (high levels of calcium in the blood) or a history of skull tumors. It is also not recommended for pregnant or breastfeeding women.